Arteriocyte is now a part of Isto Biologics.

News + Views


ISTO Technologies is a 2015 Recipient of a Becker’s Healthcare Spine Device Award!

Jun 10, 2015


ISTO Technologies has recently been awarded with Becker’s Healthcare Spine Device Award for InQu, a novel biosynthetic bone graft extender and substitute. This honor is awarded to companies who have demonstrated unwavering leadership within and dedication to the spine community. With this year’s award the Becker’s Healthcare team is proud to highlight novel technologies that are making an impact on spine surgery today and shaping the future of spine.

The award will be presented at Becker’s 13th Annual Spine, Orthopedic & Pain Management-Driven ASC + The Future of Spine in Chicago on June 12, 2015. Twenty-five medical devices, including InQu, were selected to receive this year’s award.

ISTO Technologies is a privately-held orthobiologics company dedicated to improving patient quality of life by using the science of human biology to advance solutions for spine, orthopedics, and sports medicine. ISTO currently offers a unique osteoconductive bone graft extender & substitute called InQu®, an osteoinductive human trabecular bone graft called Influx®, and a concentrated bone marrow aspirate system, CellPoint™.

To top